Art + Cultural and Creative Products Giving New Life to Cultural Relics
An international themed achievement exhibition of “THE BIG DRAW ‒ Ar[t]chaeology: Convergence of Art with Sanxingdui” was held at the Sanxingdui Museum on November 16, 2022.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221116006124/en/
(Photo: Business Wire)
“THE BIG DRAW, UK Arts Charity launched ‒ Ar[t]chaeology: Convergence of Art with Sanxingdui” was co-hosted by Sichuan Provincial Department of Culture and Tourism, Deyang Municipal People’s Government, Sichuan Provincial Cultural Heritage Administration, and Hong Kong Trade Development Council; co-organised by Sichuan Publicity Information Center for Culture and Tourism, Sichuan Provincial Academy of Arts, and Management Committee of Sanxingdui Museum; supported by Sichuan Provincial Cultural Relics and Archaeology Research Institute and Deyang Municipal Bureau of Culture, Radio, TV and Tourism. Since the event was launched in June 2022, it has attracted 33 renowned artists from 22 countries and regions and nearly 2,000 participants from over 80 schools and universities.
Yan Sashuang, Vice Director General of Sichuan Provincial Department of Culture and Tourism, presided over the event of the themed achievement exhibition. Dai Yunkang, Vice Director General of the Publicity Department of the CPC Sichuan Provincial Committee, addressed the event. Dai pointed out that Sichuan is a renowned tourist destination in China for its unique Ba-Shu culture and ancient Shu culture. This event attracted artists, art lovers and children worldwide to portray Sanxingdui in their eyes, breathing new life into cultural relics.
He Ping, vice mayor of Deyang Municipal People’s Government, said this event significantly promoted the creative inheritance of Sanxingdui culture and opened a new chapter in the innovative application of cooperation outcomes.
Jacky Chung, Director of the Chinese mainland of Hong Kong Trade Development Council, pointed out that the event is another proof of the in-depth cooperation between Sichuan’s museums and cultural institutions and Hong Kong-funded enterprises.
Kam Panesar, The Big Draw Brand Ambassador in China said, “The UK's expertise in museum and galleries culture and creative tourism is world class. Together with Sichuan Provisional Bureau for Culture and Tourism is an ingrained part of the UK's Arts & Cultural knowledge to implement people centred cultural and artistic festivals in both the UK and China.”
Sanxingdui Culture and Tourism Development Co., Ltd. and BRDGS Partners Group signed an agreement on cultural and creative products cooperation at the site.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221116006124/en/
Contact information
Sichuan Provincial Department Of Culture and Tourism
Lai Cheuk Fay
ylai18200130301@163.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Enginzyme and AGC Create Scalable Process for Key mRNA Ingredient12.1.2026 07:00:00 EET | Press release
At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹ΨTP). The rapid growth of mRNA-based vaccines and therapeutics has driven significant demand for modified nucleotides like m¹ΨTP, which enhances mRNA stability and expression, while reducing immunogenicity. Enginzyme is a deep-tech company delivering optimized biomanufacturing solutions through cell-free enzyme engineering technology. AGC Inc. is a leading global player in fields spanning from architectural glass to chemicals and life science. AGC Inc. provides services in a wide range of life science fields, from synthetic pharmaceuticals and agrochemicals, to biopharmaceuticals and leading-edge cell and gene therapies, as well as messenger RNAs. The presentation in November detailed the latest collaboration between the companies, with a focus on the biomanufacturing of nucleotides for mRNA therapy,
Ant International Partners with Google’s Universal Commerce Protocol to Expand AI Capabilities12.1.2026 03:15:00 EET | Press release
Ant International, a leading global payment, digitisation, and financial technology provider, is collaborating on the launch of Google’s Universal Commerce Protocol (UCP), a new open standard for agentic commerce that works across the entire shopping journey — from discovery and buying to post-purchase support. UCP establishes a common language for agents and systems to operate together across consumer surfaces, businesses, and payment providers to enable commerce. So instead of requiring unique connections for every individual agent, UCP enables all agents to interact easily. UCP is built to work across verticals and is compatible with existing industry protocols like Agent2Agent (A2A), Agent Payments Protocol (AP2), and Model Context Protocol (MCP). “For agentic commerce to scale, it’s critical for the industry to align on a common set of standards. We are proud to have Ant International endorse the Universal Commerce Protocol as the foundation for that future,” said Ashish Gupta, VP
Torq Secures $140M Series D at $1.2B Valuation to Lead the AI SOC and Agentic AI Era11.1.2026 18:59:00 EET | Press release
Torq, the established Agentic AI security operations pioneer, today announced it has closed a massive $140 million Series D funding round, propelling its valuation to $1.2 billion and total funding to $332M. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112510774/en/ Led by Merlin Ventures—a leading cybersecurity fund renowned for its deep access to the U.S. commercial and Public Sector markets—with participation from all existing investors, including Evolution Equity Partners, Notable Capital, Bessemer Venture Partners, Insight Ventures Partners, and Greenfield Partners, this capital injection is a definitive investment in the future of security. Torq is driving the industry’s critical shift: the complete transformation of the Security Operations Center (SOC) through battle-tested AI Agents at enterprise scale. The new funds will accelerate the adoption of the Torq AI SOC Platform, the only end-to-end solution built on
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 14:00:00 EET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreement were not disclosed. “This new agreement builds upon our recent co-development collaboration with Acepodia, which has focused on the evaluation and selection
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 12:08:00 EET | Press release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom